253 related articles for article (PubMed ID: 9554328)
1. An analysis of watchful waiting for clinically localized prostate cancer.
Steinberg GD; Bales GT; Brendler CB
J Urol; 1998 May; 159(5):1431-6. PubMed ID: 9554328
[TBL] [Abstract][Full Text] [Related]
2. The watchful waiting management option for older men with prostate cancer: state of the science.
Wallace M; Bailey D; O'Rourke M; Galbraith M
Oncol Nurs Forum; 2004 Nov; 31(6):1057-66. PubMed ID: 15547629
[TBL] [Abstract][Full Text] [Related]
3. The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidity.
Adolfsson J; Tribukait B; Levitt S
Eur Urol; 2007 Oct; 52(4):1028-35. PubMed ID: 17467883
[TBL] [Abstract][Full Text] [Related]
4. Critical review: is watchful waiting a viable management option for older men with prostate cancer?
Bailey DE; Wallace M
Am J Mens Health; 2007 Mar; 1(1):18-28. PubMed ID: 19482780
[TBL] [Abstract][Full Text] [Related]
5. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era.
Carter CA; Donahue T; Sun L; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Jackmaan S; Moul JW
J Clin Oncol; 2003 Nov; 21(21):4001-8. PubMed ID: 14581423
[TBL] [Abstract][Full Text] [Related]
6. Conservative management of prostate cancer in the prostate specific antigen era: the incidence and time course of subsequent therapy.
Zietman AL; Thakral H; Wilson L; Schellhammer P
J Urol; 2001 Nov; 166(5):1702-6. PubMed ID: 11586206
[TBL] [Abstract][Full Text] [Related]
7. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
[TBL] [Abstract][Full Text] [Related]
8. Do older men benefit from curative therapy of localized prostate cancer?
Alibhai SM; Naglie G; Nam R; Trachtenberg J; Krahn MD
J Clin Oncol; 2003 Sep; 21(17):3318-27. PubMed ID: 12947068
[TBL] [Abstract][Full Text] [Related]
9. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
10. Cancer of the prostate.
Bracarda S; de Cobelli O; Greco C; Prayer-Galetti T; Valdagni R; Gatta G; de Braud F; Bartsch G
Crit Rev Oncol Hematol; 2005 Dec; 56(3):379-96. PubMed ID: 16310371
[TBL] [Abstract][Full Text] [Related]
11. [Adenocarcinoma of the prostate].
Dvorácek J
Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
[TBL] [Abstract][Full Text] [Related]
12. [Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].
Soulié M; Villers A; Richaud P; Prapotnich D; Ruffion A; Grosclaude P
Prog Urol; 2001 Dec; 11(6):1195-204. PubMed ID: 11859652
[TBL] [Abstract][Full Text] [Related]
13. Watching, waiting and uncertainty in prostate cancer.
Bailey DE; Wallace M; Mishel MH
J Clin Nurs; 2007 Apr; 16(4):734-41. PubMed ID: 17402955
[TBL] [Abstract][Full Text] [Related]
14. [Watchful waiting for elderly patients with localized prostate cancer].
Maeda O; Kakimoto K; Ono Y; Meguro N; Kinouchi T; Usami M
Hinyokika Kiyo; 2005 Aug; 51(8):561-3. PubMed ID: 16164273
[TBL] [Abstract][Full Text] [Related]
15. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.
Konety BR; Cowan JE; Carroll PR;
J Urol; 2008 May; 179(5):1797-803; discussion 1803. PubMed ID: 18343440
[TBL] [Abstract][Full Text] [Related]
16. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.
Zelefsky MJ; Marion C; Fuks Z; Leibel SA
J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785
[TBL] [Abstract][Full Text] [Related]
17. "Just Another Statistic".
Machtay M; Glatstein E
Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
[TBL] [Abstract][Full Text] [Related]
18. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.
Arredondo SA; Downs TM; Lubeck DP; Pasta DJ; Silva SJ; Wallace KL; Carroll PR
J Urol; 2008 May; 179(5 Suppl):S14-8. PubMed ID: 18405740
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
[TBL] [Abstract][Full Text] [Related]
20. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
